We purified human procollagen type I carboxyl-terminal propeptide (PICP) that had been cleaved as in vivo from procollagen.
abbreviations: PICP, procollagen type I C-terminal propeptide; SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis; PBSA, 10 mmol/L sodium phosphate buffer, pH 7.4,0.14 moIIL NaC1, and 15 mmoIIL NaN,; and PIIICP, procollagen type Ill C-terminal propeptide.
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growth, and PICP measurements can be used to monitor normal and abnormal growth and the efficacy of treatments of abnormal growth (5), or to indicate early adverse effects on bone formation of (e.g.) treatment with glucocorticoids (6) . In adults the serum concentration of PICP correlates with the rate of bone formation, as measured histomorphometrically (7), and deviates from normal in metabolic bone diseases (8).
Reported RIAs of human PICP (9-11) all use PICP purified from procollagen isolated from the medium of various cultured fibroblasts and treated with bacterial collagenase.
However, in the PICP isolated by these methods, the amino-terminal amino acid sequences of its component chains differ from those for PICP produced in vivo (11). Use of such PICP as calibrator in an immunoassay may lead to inaccurate results, owing to possible immunochemical differences between the assay calibratorand the analyte.
We report here a method of purifying a monocomponent preparation of intact human PICP cleaved as in vivo from procollagen (i.e., with amino-terminal sequences of its component polypeptide chains identical to those of PICP produced in vivo). PICP was purifieddirectly from the medium of cultured human fetal fibroblasts, thereby avoiding the procollagen isolation step and subsequent treatment with bacterial collagenase. We also report the application of purified PICP as tracer and primary calibrator in an RIA of PICP. The assay is simple, reliable, and suitable for the further clinical and biochemical investigation of circulating PICP. 
Materials and Methods

Materials
15 mmol/L sodium aside, 10 rnmol/L EDTA, 1 mmol/L phenyl- methanesulfonyl fluoride, 1 mmol/L N-ethylmaleimide, 1 mol/L pepstatinA, and 0.1 mmol/L sodium iodoacetate.
Purification of intact PICP cleaved in vivo-like from procollagen.
The serum-free medium was concentrated by ultrafiltration, dialyzed at 4#{176}C against 50 mmolfL NH4HCO3, freeze-dried, and subjected to chromatography on a 2.5 x 8 cm column (for 500 mL of serum-free medium) of Affi-T thiophilic agarose (16). The column was eluted with 50 mmol/L sodium phosphate buffer, pH 7.5, containing the above-mentioned proteinase inhibitors at a gradient of 1.5-0.0 mol/L (NH4)2S04 in 500 mL; the flow rate was 25 milh. The fractions containing PICP were identified by SDS-PAGE, pooled, dialyzed at 4#{176}C against 50 mmol/L NH4HCO3, freeze-dried, and gelfiltered on a 1.6 x 35 cm column of Sephacryl S-300 (17) . 
Results
Production
of serum-free cell culture medium. (Fig. 1) . corresponding to counts equal to the mean counts of the zero calibrator -3 SDro calibrator) was 0.03 nmol/L. The within-run CV was <2% and the total CV <4% ( Table 1) .
The RIA for PICP cross-reacted -0.1% with PIIICP;
i.e., a partially purified preparation of PIIICP containing -250 nmolIL PIIICP (as assessed by Coomassie Blue staining of an SDS-PAGE gel) inhibited the binding of tracer to antibody to the same degree as a solution of purified PICP containing 0.25 nmol/L PICP. Serum samples gave dilution curves that paralleled the calibration curve (Fig. 3) , and purified PICP added to serum samples was completely recovered (Table 2) .
Both serum and plasma samples can be used for the assay, and the concentrations of PICP measured in serum and in heparin-treated plasma did not differ significantly (r = 0.993, slope = 1.07, nonsignificantly different from 1.00; n = 10). The serum PICP antigen is stable in serum without any additivesfor at least 4 days at 4#{176}C (percent of initial value,mean ± SD: 98.3% ± 3.0%; n = 7). Furthermore, the PICP concentration in serum samples is stable for months at -20#{176}C [percent of initial value, n = 6: 96.1% ± 2.3% (after 35 days); 95.4% ± 4.3% (after 92 days) The importance of the thiophffic adsorption chromatographic step lies in the fact that it separates free PICP from free PIIICP, which closely resembles PICP-65.1% amino acid sequence identity between their al chains (19, 24) and extensive structural similarities (24). The PICP RIA presented here was sensitive and precise throughout the measuring range. The assay signal is independent of whether PICP is dissolved in assay buffer or in serum, as shown by the recovery experiment (Table 2 ) and the fact that dilution curves of serum samples are parallel to the calibration curve (Fig. 3) ; i.e., there is no matrix effect.
The cross-reaction with PIIICP was very small, and, given that the partially purified preparation of PIIICP used for testing the cross-reaction probably contained trace amounts of PICP, the true cross-reaction with PIIICP seems negligible.
Furthermore, the serum concentration of PIIICP is probably lower than the concentration of PICP, the total body content of type I collagen being much higher than the content of type III collagen (1).
Because 
